Drug Database
Back to search

Denmark· DK-28105128112

Vipdomet

A metformin and alogliptin product containing alogliptinbenzoat, metforminhydrochlorid, registered in Denmark by Takeda Pharma A/S. The same ATC class is registered in 10 of our 19 countries.

ATC A10BD13

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedVipdometATCA10BD13REGISTER NO.DK-28105128112PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alogliptinbenzoat, metforminhydrochloridAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and alogliptin is registered in 10 of 19 countries.

Countries holding a registration under ATC A10BD13 (metformin and alogliptin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 5 of them publish a price we can compare per daily dose
Search metformin and alogliptin products by name

Metformin and alogliptin · ATC A10BD13

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Alogliptinbenzoat, METFORMINHYDROCHLORID
Manufacturer
Takeda Pharma A/S
Country
Denmark (DK)
ATC code
A10BD13
ATC class
Metformin and alogliptin
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105128112

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and alogliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and alogliptin against other medicinesHow interaction checks work

Metformin and alogliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under A10BD13

Metformin and alogliptin, as other registers publish it.

All metformin and alogliptin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb1554c5-1712-42bc-b23d-1ceccba9bebb
GET /v1/drugs/cb1554c5-1712-42bc-b23d-1ceccba9bebb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "12.5 mg/1000 mg",
  "auth_role": "MOD",
  "dk_drugid": "28105128112",
  "substance": "Alogliptinbenzoat, METFORMINHYDROCHLORID",
  "auth_procedure": "Central",
  "in_medicinpriser": true,
  "registration_date_serial": "41536"
}
API referenceMCP serverPlans

See everything about metformin and alogliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console